Bnb Plus Corp.
BNB Plus Corp. operates as a biotechnology and digital asset company, generating revenue through therapeutic DNA production, DNA tagging and security products, and a digital asset treasury strategy involving BNB tokens and stablecoins.
Business. BNB PLUS CORP. (BNBX) is an investment management and fund operator that provides asset management and custody services. The company operates within the Financials sector, specifically under the Banking & Investment Services business sector. BNB PLUS CORP. is headquartered in the United States and is listed on the Nasdaq stock exchange. Specific details regarding operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
1Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-07-28 · estimated
- Macro
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
BNB PLUS CORP. (BNBX) is an investment management and fund operator that provides asset management and custody services. The company operates within the Financials sector, specifically under the Banking & Investment Services business sector. BNB PLUS CORP. is headquartered in the United States and is listed on the Nasdaq stock exchange. Specific details regarding operating segments and geographic revenue mix are not available.
BNB Plus Corp. maintains a debt-free capital structure with a debt-to-equity ratio of 0.0 and a current ratio of 1.82, indicating adequate short-term liquidity coverage despite a net loss of $25.26 million in Q2 2026. The company holds $949,091 in cash and equivalents, supplemented by significant digital asset holdings including $1.34 million in digital assets, $3.71 million in digital asset receivables, and $5.40 million in digital asset trust investments. The market capitalization stands at $3.25 million, trading at a price-to-book ratio of 0.34, reflecting a deep discount to tangible book value of $12.51 million.
Profitability metrics are severely negative, with a return on equity of -2.02 and return on assets of -1.85, driven by operating losses of $25.46 million against gross profit of $1.14 million. The company reports substantial non-cash expenses, including $8.83 million in warrants issued to consultants and $968,064 in stock-based compensation, alongside unrealized losses on digital assets. These losses have accumulated to a deficit of $404.45 million in retained earnings, eroding shareholder equity despite recent capital raises.
- Debt-free balance sheet with $12.51 million in equity, but eroded by $404.45 million in accumulated deficit.
- High dilution risk with diluted shares (8.87M) nearly double the basic share count (4.77M) due to warrants and options.
- Strategic pivot to digital asset treasury, holding $10.45 million in digital assets and trust investments.
- Operating losses of $25.46 million in Q2 2026, driven by non-cash expenses and unrealized digital asset losses.
- Recent capital raises of $24.90 million via PIPE and ATM offerings to fund operations and digital asset purchases.
- Going-concern doubts flagged in filings, highlighting dependency on future capital or revenue growth.
Bull / Bear case
Generated · model-assistedThe company trades at a 0.34 price-to-book ratio, suggesting significant undervaluation relative to its tangible book value of $9.4 million.
Net income improved by 53.9% year-over-year in FY2025, indicating a meaningful reduction in losses compared to the prior period.
Total assets surged 188.2% year-over-year to $12.8 million in FY2025, reflecting substantial balance sheet expansion and growth potential.
Equity grew 296.7% year-over-year to $9.1 million in FY2025, demonstrating strong capital accumulation despite ongoing operational losses.
The debt-to-equity ratio of 0.0 ranks above the cohort median, indicating a conservative capital structure with minimal leverage risk.
The company faces high dilution risk, which threatens existing shareholder value and could significantly reduce earnings per share over time.
High liquidity risk flags suggest potential difficulties in meeting short-term obligations, raising concerns about financial stability and operational continuity.
Return on equity stands at -2.02%, placing the company in the bottom quartile of its investment management cohort peers.
Operating income deteriorated to -$16.0 million in FY2025, highlighting persistent inability to generate core operational profitability from business activities.
Free cash flow was negative $14.1 million in FY2024, indicating severe cash burn and reliance on external financing for operations.
In focus — financials by report
Operating income -$25.5M.
- ▍Operating income -$25.5M
Operating income -$18.7M.
- ▍Operating income -$18.7M
Operating income -$16.0M.
- ▍Operating income -$16.0M
Operating income -$14.0M.
- ▍Operating income -$14.0M
Operating income -$13.7M.
- ▍Operating income -$13.7M
Operating income -$11.0M.
- ▍Operating income -$11.0M
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Diluted share count is materially above the basic share count.
- Filings reference going-concern or substantial-doubt language.
- Source documents mention dilution or offering risk.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Non-Qualified Stock Option (right to buy) → Common StockAcquired 77 038 @ $0,69grant · 2026-03-27
- Director, Chairman of the Board · Incentive Stock Option (right to buy) → Common StockAcquired 77 038 @ $0,69grant · 2026-03-27
- Director · Incentive Stock Option (right to buy) → Common StockAcquired 77 038 @ $0,69grant · 2026-03-27
- Director · Incentive Stock Option (right to buy) → Common StockAcquired 77 038 @ $0,69grant · 2026-03-27
- Director · Incentive Stock Option (right to buy) → Common StockAcquired 77 038 @ $0,69grant · 2026-03-27
- Director · Incentive Stock Option (right to buy) → Common StockAcquired 77 038 @ $0,69grant · 2026-03-27
- Director · Non-Qualified Stock Option (right to buy) → Common StockAcquired 12 270 @ $1,31grant · 2026-02-02
- Director · Incentive Stock Option (right to buy) → Common StockAcquired 80 730 @ $1,31grant · 2026-02-02
- Chief Executive Officer · Incentive Stock Option (right to buy) → Common StockAcquired 42 194 @ $2,52grant · 2025-12-15
- Chief Financial Officer · Non-Qualified Stock Option (right to buy) → Common StockAcquired 42 194 @ $2,52grant · 2025-12-15
- Chief Financial Officer · Incentive Stock Option (right to buy) → Common StockAcquired 42 194 @ $2,52grant · 2025-12-15
- Chief Executive Officer · Non-Qualified Stock Option (right to buy) → Common StockAcquired 42 194 @ $2,52grant · 2025-12-15
Actions
Ask Handelsavisen
- Market data
- Regulatory filings
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Enterprise Valuemarket_cap - net_cash
- Return On Equitynet_income / total_equity
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Price To Tangible Bookmarket_price / (tangible_book_value / shares_outstanding_diluted)
- BNB PLUS CORP. company facts · 2026-07-13
- BNB PLUS CORP. 10-Q 2026-05-15 · 2026-07-13
- BNB PLUS CORP. 10-Q 2026-02-12 · 2026-07-13
- BNB PLUS CORP. 10-K 2025-12-22 · 2026-07-13
- BNB PLUS CORP. 10-Q 2025-08-14 · 2026-07-13
- 8-K (sec_8k_material) on BNBX · 2026-07-13
- BNB Plus Corp Market data — analyst estimates · 2026-07-13
- BNB PLUS CORP. HA canonical relationships · 2026-07-13
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
- Chief Financial Officer · Common StockOther 18 691 · 2025-10-17
- Director · Common StockOther 22 511 · 2025-10-17
- Director · Common StockOther 22 511 · 2025-10-17
- Director · Common StockOther 22 511 · 2025-10-17
- Director · Common StockOther 22 511 · 2025-10-17
- Director · Common StockOther 18 691 · 2025-10-17
- Chief Executive Officer · Common StockOther 18 691 · 2025-10-17
Short positioning
Geographic breakdown
Intel & risk
no material change vs prior analysis (walked 17 fields; 4 schema-expansion field(s) excluded)
- Narrative— → —medium
- Conclusion— → —medium
Evidence & claims
From filings & derived data- Total assets (annual): USD 20.7MUnknown
- Shares outstanding (annual): 4.77MUnknown
- Cash & equivalents (annual): USD 2.45MUnknown
- Shareholders' equity (annual): USD 18.84MUnknown
- Current assets (annual): USD 5.11MUnknown
- Total liabilities (annual): USD 2.24MUnknown
- Current liabilities (annual): USD 2.21MUnknown
- Gross profit (annual): USD 838.91KUnknown
- EPS (basic) (annual): USD-PER-SHARES -134Unknown
- Total operating expenses (annual): USD 16.89MUnknown
- Cost of revenue (annual): USD 1.3MUnknown
- Pre-tax income (annual): USD -15.64MUnknown
- Capex (annual): USD 313.12KUnknown
- R&D expense (annual): USD 6.02MUnknown
- Operating income (annual): USD -16.05MUnknown
- EPS (diluted) (annual): USD-PER-SHARES -134Unknown
- Net income (annual): USD -15.16MUnknown
- Shares outstanding (annual): 54.11MUnknown
- Total liabilities (annual): USD 3.42MUnknown
- Current liabilities (annual): USD 2.39MUnknown
- Current assets (annual): USD 11.28MUnknown
- Cash & equivalents (annual): USD 9.29MUnknown
- Shareholders' equity (annual): USD 12.75MUnknown
- Total assets (annual): USD 15.97MUnknown